Arthritis Consumer Experts today announced the launch of the Biosim•Exchange
Arthritis Consumer Experts today announced the launch of the Biosim•Exchange – the first central resource in Canada for consumers to find timely, fact-based information on biosimilars safety and effectiveness and report on public and private health insurance formulary policy or listing decisions on biosimilars.
“There is a real need for balanced, evidence-based information on biosimilars. Our aim with the Biosim•Exchange is to help patients better understand biosimilars and their place among other inflammatory arthritis treatments. With this knowledge, patients can have a full therapy conversation with their rheumatologist (or other specialist) in order to best decide on their choice of medications, including originator biologics or biosimilars,” said Cheryl Koehn, Founder & President, Arthritis Consumer Experts.
To view the Biosim•Exchange, please click here: http://bit.ly/JHBiosimExch.
ACE encourages you to share the Biosim•Exchange with other patients, your friends and family.
We look forward to your questions and comments and hearing about your experience with biosimilars.